FSD Liabilities And Stockholders Equity from 2010 to 2024
HUGE Stock | USD 0.32 0.01 3.03% |
Liabilities And Stockholders Equity | First Reported 2016-06-30 | Previous Quarter 18.9 M | Current Value 17.4 M | Quarterly Volatility 22.4 M |
Check FSD Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among FSD main balance sheet or income statement drivers, such as Interest Expense of 289, Selling General Administrative of 10.1 M or Total Revenue of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 278, Dividend Yield of 0.0 or PTB Ratio of 2.9. FSD financial statements analysis is a perfect complement when working with FSD Pharma Valuation or Volatility modules.
FSD | Liabilities And Stockholders Equity |
Latest FSD Pharma's Liabilities And Stockholders Equity Growth Pattern
Below is the plot of the Liabilities And Stockholders Equity of FSD Pharma Class over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. FSD Pharma's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in FSD Pharma's overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity | 10 Years Trend |
|
Liabilities And Stockholders Equity |
Timeline |
FSD Liabilities And Stockholders Equity Regression Statistics
Arithmetic Mean | 18,651,647 | |
Geometric Mean | 0.00 | |
Coefficient Of Variation | 115.40 | |
Mean Deviation | 18,612,216 | |
Median | 10,878,484 | |
Standard Deviation | 21,523,602 | |
Sample Variance | 463.3T | |
Range | 63M | |
R-Value | 0.73 | |
Mean Square Error | 235.7T | |
R-Squared | 0.53 | |
Significance | 0 | |
Slope | 3,495,899 | |
Total Sum of Squares | 6485.7T |
FSD Liabilities And Stockholders Equity History
About FSD Pharma Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include FSD Pharma income statement, its balance sheet, and the statement of cash flows. FSD Pharma investors use historical funamental indicators, such as FSD Pharma's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Although FSD Pharma investors may use each financial statement separately, they are all related. The changes in FSD Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on FSD Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on FSD Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in FSD Pharma. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Liabilities And Stockholders Equity | 17.4 M | 25.4 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.C | Citigroup | |
CRM | Salesforce | |
MSFT | Microsoft |
Check out the analysis of FSD Pharma Correlation against competitors. Note that the FSD Pharma Class information on this page should be used as a complementary analysis to other FSD Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for FSD Stock analysis
When running FSD Pharma's price analysis, check to measure FSD Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FSD Pharma is operating at the current time. Most of FSD Pharma's value examination focuses on studying past and present price action to predict the probability of FSD Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FSD Pharma's price. Additionally, you may evaluate how the addition of FSD Pharma to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is FSD Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FSD Pharma. If investors know FSD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FSD Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Quarterly Revenue Growth (0.07) | Return On Assets (0.43) | Return On Equity (0.84) |
The market value of FSD Pharma Class is measured differently than its book value, which is the value of FSD that is recorded on the company's balance sheet. Investors also form their own opinion of FSD Pharma's value that differs from its market value or its book value, called intrinsic value, which is FSD Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FSD Pharma's market value can be influenced by many factors that don't directly affect FSD Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FSD Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if FSD Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FSD Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.